Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
34.48
-1.11 (-3.12%)
At close: Feb 11, 2026, 4:00 PM EST
34.63
+0.15 (0.44%)
After-hours: Feb 11, 2026, 5:33 PM EST
Vericel Market Cap
Vericel has a market cap or net worth of $1.75 billion as of February 11, 2026. Its market cap has decreased by -40.58% in one year.
Market Cap
1.75B
Enterprise Value
1.71B
1-Year Change
-40.58%
Ranking
Category
Stock Price
$34.48
Market Cap Chart
Since December 1, 1998, Vericel's market cap has increased from $31.90M to $1.75B, an increase of 5,390.21%. That is a compound annual growth rate of 15.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.80B | -1.17% |
| Dec 31, 2025 | 1.82B | -32.80% |
| Dec 31, 2024 | 2.71B | 59.48% |
| Dec 29, 2023 | 1.70B | 36.63% |
| Dec 30, 2022 | 1.24B | -32.39% |
| Dec 31, 2021 | 1.84B | 31.15% |
| Dec 31, 2020 | 1.40B | 80.38% |
| Dec 31, 2019 | 777.70M | 3.12% |
| Dec 31, 2018 | 754.20M | 296.53% |
| Dec 29, 2017 | 190.20M | 163.07% |
| Dec 30, 2016 | 72.30M | 17.75% |
| Dec 31, 2015 | 61.40M | -15.08% |
| Dec 31, 2014 | 72.30M | 412.77% |
| Dec 31, 2013 | 14.10M | -74.46% |
| Dec 31, 2012 | 55.20M | -21.48% |
| Dec 30, 2011 | 70.30M | -2.77% |
| Dec 31, 2010 | 72.30M | 35.14% |
| Dec 31, 2009 | 53.50M | -20.74% |
| Dec 31, 2008 | 67.50M | -2.17% |
| Dec 31, 2007 | 69.00M | -53.19% |
| Dec 29, 2006 | 147.40M | -32.17% |
| Dec 30, 2005 | 217.30M | 65.88% |
| Dec 31, 2004 | 131.00M | 38.19% |
| Dec 31, 2003 | 94.80M | 321.33% |
| Dec 31, 2002 | 22.50M | -45.78% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sarepta Therapeutics | 1.94B |
| Aurinia Pharmaceuticals | 1.90B |
| Stoke Therapeutics | 1.85B |
| Syndax Pharmaceuticals | 1.83B |
| RAPT Therapeutics | 1.78B |
| Ardelyx | 1.78B |
| MBX Biosciences | 1.78B |
| MannKind | 1.77B |